Discontinued — last reported Q1 '23

Business Segments · Asset impairments

Proprietary Products — Asset impairments

Analysis

StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ1 2023
Rolls up toImpairment Charges

How to read this metric

High impairment charges signal poor past investment decisions or deteriorating market conditions for the segment's products.

Detailed definition

Asset impairments represent the reduction in the carrying value of long-lived assets when their fair value falls below t...

Peer comparison

Standard 'Impairment of Long-Lived Assets' reported by capital-intensive companies.

Metric ID: wst_segment_proprietary_products_asset_impairments

Historical Data

1 periods
 Q1 '23
Value$9.40M

Similar Metrics at Other Companies

Fidelity National Information Services logo
Fidelity National Information ServicesFISView metric
Woodward logo
WoodwardWWDView metric
Dow logo
DowDOWView metric
Verisk Analytics, Inc. logo
Verisk Analytics, Inc.VRSKView metric
Tyson Foods logo
Tyson FoodsTSNView metric
Constellation Brands logo
Constellation BrandsSTZView metric

Frequently Asked Questions

What is West Pharmaceutical Services's proprietary products — asset impairments?
West Pharmaceutical Services (WST) reported proprietary products — asset impairments of $9.40M in Q1 2023.
What does proprietary products — asset impairments mean?
A non-cash charge taken when the value of an asset is deemed to have permanently declined.